InsiderTrades

Form 4 for TMDX TransMedics Group, Inc.

Accepted 2026-07-14 21:28:24 ET · period of report 2026-07-10 · accession 0001193125-26-303704 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-07-14 21:28 2026-07-10 TMDX Hassanein Waleed H Pres, CEO, Dir A - Grant $0.00 +49.7K 171.1K +41% $0
D 2026-07-14 21:28 2026-07-10 TMDX Hassanein Waleed H Pres, CEO, Dir A - Grant $0.00 +113.0K 113.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-07-10 A A 49,669 $0.00 171,093 D — — (F1) Consists of 49,669 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
2 Derivative Stock Option (Right to Buy) 2026-07-10 A A 112,984 $0.00 112,984 D $71.23 · — to 2036-07-10 112,984 Common Stock (F3) The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following April 10, 2026 until the option is fully vested on April 10, 2030, subject to continued service.